⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 1, 2024Journal of Family Medicine and Primary CareOpen Access

Initiation or switch to insulin degludec/insulin aspart in adults with type 2 diabetes in India: Results from a prospective, non-interventional, real-world study

Manash Baruah Pankaj Aneja Shailesh Pitale Abhijit Bhograj Ritesh Kumar Agrawala Ajay Aggarwal Prasad Gurumallappa Mahadev Deepaklal Chhabrai Madhavdas Sanjay Shah Mathew John Muzammil Khan A Pathan Manjunatha Revanna Manu Chandrappa Kiran P. Singh

View Full Paper

Ask AI

Bookmark

Share

Abstract

To investigate clinical outcomes in adults with type 2 diabetes (T2D) after insulin degludec/insulin aspart (IDegAsp) treatment in a real-world setting.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Baruah et al. (2024) studied this question.

synapsesocial.com/papers/68e59f9eb6db6435875399f2 https://doi.org/10.4103/jfmpc.jfmpc_1401_23

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Initiating or switching to insulin degludec/insulin aspart in a real‐world population of adults with type 2 diabetes in <scp>Australia</scp>: results from a prospective, non‐interventional study2024 · 1 citations
2Efficacy and Safety of IDegAsp in a Real-World Korean Population with Type 2 Diabetes Mellitus2024 · 3 citations
3Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults With Type 2 Diabetes in the Philippines2024 · 1 citations
4Efficacy and safety of insulin degludec/aspart in patients with type 2 and type 1 diabetes mellitus: real-world evidence from Indonesia2025
519-PUB: Improved Glycemic Control in People with Type 2 Diabetes (T2D) Initiating or Switching to Insulin Degludec/Insulin Aspart (IDegAsp) in a Real-World Setting in China2024